SEC Form 4 research
| Issuer | Mineralys Therapeutics, Inc. |
|---|---|
| Tickers | MLYS |
| Reporting owners | 25 |
| Officers and directors | 8 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-09-30 | Congleton Jon | S | 75,000 | $25.46 | Not reported |
| 2026-09-24 | 2026-09-22 | Slingsby Brian Taylor | S | 104,320 | $28.81 | Not reported |
| 2026-09-22 | 2026-09-21 | Warren Eric | S | 7,438 | $28.12 | Not reported |
| 2026-09-17 | 2026-09-15 | Karydas Daphne | S | 3,000 | $28.58 | Not reported |
| 2026-08-25 | 2026-08-21 | Warren Eric | S | 7,437 | $25.98 | Not reported |
| 2026-08-12 | 2026-08-10 | Ferguson James J. III | A | 102,400 | $0 | Not reported |
| 2026-08-12 | 2026-08-10 | Ferguson James J. III | A | 135,000 | $0 | Not reported |
| 2026-08-12 | 2026-08-10 | Rodman David Malcom | S | 2,170 | $27.09 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.